Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - TOTAL EQUITY
Total Equity URGN - UroGen Pharma Ltd.
-65.2 M
LAST VALUE
-195.83%
2 YEAR CAGR
-11.51%
5 YEAR CAGR
-37.86%
10 YEAR CAGR